Product
attIL2-T cells
1 clinical trial
2 indications
Indication
Soft Tissue SarcomaIndication
Bone SarcomaClinical trial
A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone SarcomaStatus: Recruiting, Estimated PCD: 2025-09-30